Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.27 USD | +0.47% | -10.25% | -10.04% |
Apr. 16 | Leerink Partners Starts AnaptysBio With Outperform Rating, $47 Price Target | MT |
Apr. 11 | Wells Fargo Initiates AnaptysBio With Overweight Rating, $56 Price Target | MT |
Financials (USD)
Sales 2024 * | 16.39M | Sales 2025 * | 25.59M | Capitalization | 513M |
---|---|---|---|---|---|
Net income 2024 * | -178M | Net income 2025 * | -196M | EV / Sales 2024 * | 14.1 x |
Net cash position 2024 * | 283M | Net cash position 2025 * | 316M | EV / Sales 2025 * | 7.72 x |
P/E ratio 2024 * |
-3.03
x | P/E ratio 2025 * |
-3.27
x | Employees | 117 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.6% |
Latest transcript on AnaptysBio, Inc.
1 day | +0.47% | ||
1 week | -9.70% | ||
Current month | -14.43% | ||
1 month | -11.08% | ||
3 months | -19.81% | ||
6 months | +9.74% | ||
Current year | -10.04% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Faga
CEO | Chief Executive Officer | 44 | 21-11-25 |
Dennis Mulroy
DFI | Director of Finance/CFO | 69 | 20-07-14 |
Paul Lizzul
CTO | Chief Tech/Sci/R&D Officer | 49 | 20-07-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hollings Renton
BRD | Director/Board Member | 77 | 15-06-29 |
Dennis Fenton
BRD | Director/Board Member | 72 | 18-03-04 |
Magda Marquet
BRD | Director/Board Member | 65 | 21-01-17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.07% | 0 M€ | 0.00% | - | |
0.02% | 509 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 19.27 | +0.47% | 385,671 |
24-04-23 | 19.18 | -2.44% | 387,321 |
24-04-22 | 19.66 | -1.06% | 139,714 |
24-04-19 | 19.87 | +0.20% | 288,943 |
24-04-18 | 19.83 | -7.64% | 363,855 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.04% | 513M | |
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |
- Stock Market
- Equities
- ANAB Stock